Overview

To Onyx’s knowledge, all press releases, scientific papers, and abstracts and the information contained within them were timely and accurate when issued. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. Onyx has no intention of updating this information, and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.

Please see Terms of Use for this website.

Corporate Fact Sheet: Q1 2011

Corporate Presentation: May 2011

Investor Relations Contacts

Traci McCarty Julie Wood
650.266.2398 650.266.2505

Onyx Pharmaceuticals, Inc.
249 E. Grand Avenue
South San Francisco, CA 94080

Stock Quote (update every 15 minutes): As of 4:00pm - 5/20/2011

  • Symbol
    ONXX
  • Last
    43.71 +0.22
  • Open
    43.46
  • High
    43.81
  • Low
    42.49
  • Volume
    1139204